非 PVC 滴灌袋市场规模、份额、成长分析（按产品、材料、内容、地区）- 按行业预测，2024-2031 年

2022年全球非PVC滴灌袋市场规模为16.7亿美元，从2023年的18.5亿美元成长到2031年的42.4亿美元，在预测期内（2024-2031年）预计将以复合年增长率增长。年增长10.9%。

由于非 PVC IV 袋在处理和运输方面固有的安全性和实用性，尤其是在手术室和肿瘤科领域，非 PVC IV 袋市场预计将显着成长。随着人们越来越关注污染预防和最大限度地降低传统 PVC 输液袋（可能会滤出有害化合物）相关的风险，聚丙烯和 EVA 等非 PVC 替代品越来越受欢迎。这些袋子不仅可以保护药物的完整性，而且也易于处理。它在肠外营养和化疗的主要用途凸显了它在医疗保健中的重要作用。随着各种创新材料的出现，对非 PVC IV 袋的需求预计将增加，反映出 PVC 包装的广泛转变，并增强了其在多种医疗应用中的价值。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境

非PVC滴灌袋市场规模：依产品分类

• 市场概况
• 单室
• 多室

非PVC滴灌袋市场规模：依材质

• 市场概况
• 乙烯醋酸乙烯酯
• 聚丙烯
• 共聚酯醚
• 其他的

非PVC滴灌袋市场规模：依内容分类

• 市场概况
• 冷冻混合物
• 液体混合物

非PVC滴灌袋按地区市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Baxter
• B. Braun Melsungen AG
• Pfizer, Inc.（Hospira）
• Fresenius Kabi AG
• JW Life Science
• RENOLIT
• PolyCine GmbH
• Sealed Air
• ANGIPLAST PVT. LTD
• Shanghai Solve Care Co Ltd.
• Kraton Corporation
• Jiangxi Sanxin Medtec Co., Ltd.
• Otsuka Pharmaceutical Co., Ltd
• Fresenius Kabi AG
• PolyCine GmbH

结论和建议

Global Non-PVC IV Bags Market size was valued at USD 1.67 billion in 2022 and is poised to grow from USD 1.85 billion in 2023 to USD 4.24 billion by 2031, growing at a CAGR of 10.9% during the forecast period (2024-2031).

The market for non-PVC IV bags is poised for significant growth, driven by their inherent safety and practicality for handling and transport, especially in operating rooms and oncology departments. With an increased focus on contamination prevention and minimizing risks associated with traditional PVC IV bags, which can leach harmful compounds, non-PVC alternatives like polypropylene and EVA are gaining traction. These bags not only safeguard drug integrity but are also easy to dispose of. Their primary applications in parenteral feeding and chemotherapy highlight their essential role in healthcare. As various innovative materials emerge, the demand for non-PVC IV bags is expected to rise, reflecting a broader shift away from PVC packaging and reinforcing their value across multiple medical applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Pvc Iv Bags market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Pvc Iv Bags Market Segmental Analysis

Global Non-PVC IV Bags Market is segmented by product, material, content and region. Based on product, the market is segmented into single chamber and multi chamber. Based on material, the market is segmented into ethylene vinyle acetate, polypropylene, copolyester ether and others. Based on content, the market is segmented into frozen mixture and liquid mixture. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Pvc Iv Bags Market

The Global Non-PVC IV Bags market is poised for significant growth driven mainly by the increasing incidence of cancer, which necessitates both oral and intravenous drug administration. As reported by the World Health Organization (WHO), cancer is the second leading cause of mortality globally, propelling demand for effective treatment options. Additionally, the surge in patient numbers across healthcare facilities has further contributed to market expansion. This growth is also influenced by the rising need for error prevention in drug delivery, enhanced demand for advanced IV storage solutions, and stringent regulations aimed at minimizing hospital-acquired infections. Collectively, these factors are amplifying the appeal of non-PVC IV bags, especially for oncology treatments like chemotherapy and targeted therapies.

Restraints in the Global Non-Pvc Iv Bags Market

The growth of the Global Non-PVC IV Bags market could be impeded by concerns regarding phthalates leaching from medical equipment, posing risks to individuals and the environment. These apprehensions may present significant challenges for the non-PVC IV bags sector throughout the projected period. Additionally, stringent regulations governing the use and disposal of PVC are expected to create further obstacles, affecting market expansion. As a result, manufacturers and stakeholders in the non-PVC IV bags market must navigate these restrictions carefully to mitigate risks and align with evolving regulations, which could influence their operational strategies moving forward.

Market Trends of the Global Non-Pvc Iv Bags Market

The Global Non-PVC IV Bags market is poised for significant growth in the coming years, driven by the rising adoption of ethylene vinyl acetate (EVA) in blood banks and the expansion of facilities for storing blood and blood components. As awareness of the importance of safe blood storage increases, so does the demand for reliable packaging solutions. Additionally, the market for copolyester ether is expected to thrive, attributed to its unique advantages such as chemical resistance, superior durability, and clarity. These factors collectively point toward a growing trend in non-PVC IV bag usage, paralleling the global expansion of blood banks and healthcare infrastructure.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Non-Pvc Iv Bags Market Size by Product & CAGR (2024-2031)

• Market Overview
• Single Chamber
• Multi Chamber

Global Non-Pvc Iv Bags Market Size by Material & CAGR (2024-2031)

• Market Overview
• Ethylene Vinyle Acetate
• Polypropylene
• Copolyester Ether
• Others

Global Non-Pvc Iv Bags Market Size by Content & CAGR (2024-2031)

• Market Overview
• Frozen Mixture
• Liquid Mixture

Global Non-Pvc Iv Bags Market Size & CAGR (2024-2031)

• North America (Product, Material, Content)
  • USA
  • Canada
• Europe (Product, Material, Content)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Content)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Content)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Content)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Baxter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer, Inc. (Hospira)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RENOLIT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PolyCine GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sealed Air
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANGIPLAST PVT. LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Solve Care Co Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kraton Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangxi Sanxin Medtec Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PolyCine GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation